Abstract
Several investigations have unveiled multiple effects of the ployphenol curcumin on immune responses, both in physiological and in pathological conditions. Here we review the biochemistry of this compound in the context of its potential and limitations as possible therapeutic modulator of immune responses.
Keywords: Curcumin, immune response, inflammation, autoimmunity, autoimmune diseases, tumors, infection, allergy
Current Bioactive Compounds
Title: Curcumin and Immunity
Volume: 6 Issue: 3
Author(s): Antonio La Cava and Milan Fiala
Affiliation:
Keywords: Curcumin, immune response, inflammation, autoimmunity, autoimmune diseases, tumors, infection, allergy
Abstract: Several investigations have unveiled multiple effects of the ployphenol curcumin on immune responses, both in physiological and in pathological conditions. Here we review the biochemistry of this compound in the context of its potential and limitations as possible therapeutic modulator of immune responses.
Export Options
About this article
Cite this article as:
La Cava Antonio and Fiala Milan, Curcumin and Immunity, Current Bioactive Compounds 2010; 6 (3) . https://dx.doi.org/10.2174/157340710793237335
DOI https://dx.doi.org/10.2174/157340710793237335 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Proteasomes as Drug Targets
Current Drug Targets DNA Double Strand Break Repair - Related Synthetic Lethality
Current Medicinal Chemistry The miRNAs and Epithelial-Mesenchymal Transition in Cancers
Current Pharmaceutical Design Role of Genetics and Epigenetics in Mucosal, Uveal, and Cutaneous Melanomagenesis
Anti-Cancer Agents in Medicinal Chemistry Metabolism and the Paradoxical Effects of Arsenic: Carcinogenesis and Anticancer
Current Medicinal Chemistry Targeting MUC15 Protein in Cancer: Molecular Mechanisms and Therapeutic Perspectives
Current Cancer Drug Targets Inflammasome Activation in Chronic Glomerular Diseases
Current Drug Targets Pathogen-Related Signal Transduction Pathways of Dendritic Cells: Perspectives for Cancer Immunotherapy
Current Signal Transduction Therapy New Entrants into Clinical Trials for Targeted Therapy of Breast Cancer: An Insight
Anti-Cancer Agents in Medicinal Chemistry Neurokinin-1 Receptor Antagonist Can Prevent the Delayed Phase in Patients: A Single Center Retrospect Study
Anti-Cancer Agents in Medicinal Chemistry Paris Saponin VII Induces Apoptosis and Cell Cycle Arrest in Erythroleukemia Cells by a Mitochondrial Membrane Signaling Pathway
Anti-Cancer Agents in Medicinal Chemistry In-Vivo Gene Delivery by Sonoporation: Recent Progress and Prospects
Current Gene Therapy From Adipose Tissue Protein Secretion to Adipopharmacology of Disease
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Effective Treatment of Human Lung Cancer by Targeting Tissue Factor with a Factor VII-Targeted Photodynamic Therapy
Current Cancer Drug Targets CD6 as a Cell Surface Receptor and As a Target for Regulating Immune Responses
Current Drug Targets The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway
Current Clinical Pharmacology Potential Utilization of Bystander / Abscopal-Mediated Signal Transduction Events in the Treatment of Solid Tumors
Current Signal Transduction Therapy 5-Aryl-1,3,4-Thiadiazole-Based Hydroxamic Acids as Histone Deacetylase Inhibitors and Antitumor Agents: Synthesis, Bioevaluation and Docking Study
Medicinal Chemistry 4-Substituted-2-Methoxyphenol: Suitable Building Block to Prepare New Bioactive Natural-like Hydroxylated Biphenyls
Letters in Drug Design & Discovery Applications of Nanosystems to Anticancer Drug Therapy (Part II. Dendrimers, Micelles, Lipid-based Nanosystems)
Recent Patents on Anti-Cancer Drug Discovery